Published in J Int Neuropsychol Soc on January 01, 2009
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev (2009) 1.17
Predictors of pain intensity and pain functioning in patients with the hepatitis C virus. Gen Hosp Psychiatry (2010) 0.95
Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. J Clin Exp Neuropsychol (2010) 0.93
Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity. Psychiatry Res (2012) 0.85
Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int (2015) 0.84
Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression. Metab Brain Dis (2013) 0.83
Psychiatric care of the patient with hepatitis C: a review of the literature. Prim Care Companion J Clin Psychiatry (2010) 0.82
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J Gastroenterol (2015) 0.82
Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. Clin Neuropsychol (2012) 0.81
Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV. J Neuroimmunol (2013) 0.79
Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C. J Neurovirol (2013) 0.76
Cerebral Response to Peripheral Challenge with a Viral Mimetic. Neurochem Res (2015) 0.76
Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample. J Clin Exp Neuropsychol (2016) 0.75
Brain Microstructural Correlates of Cognitive Dysfunction in Clinically and Biochemically Normal Hepatitis C Virus Infection. J Clin Exp Hepatol (2017) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol (2004) 4.90
Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol (2004) 4.12
Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 3.45
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc (2002) 2.79
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology (2002) 2.26
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol (2003) 2.04
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology (2005) 2.00
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol (2001) 1.88
CLINICAL NEUROPSYCHOLOGY. Med Clin North Am (1963) 1.77
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. Clin Liver Dis (2003) 1.76
Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol (2004) 1.76
Neuropsychological impairment in patients with chronic hepatitis C. Hepatology (2002) 1.62
Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance. Neurology (2007) 1.59
Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav Immun (2003) 1.56
Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int (2007) 1.56
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology (2005) 1.49
Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol (2002) 1.42
Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc (2003) 1.39
Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychol Rev (2004) 1.37
Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol (1996) 1.33
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs (2006) 1.20
Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc (2004) 1.19
Emerging evidence of hepatitis C virus neuroinvasion. AIDS (2005) 1.14
Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat (2003) 1.13
Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand (2001) 1.09
Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. J Pain Symptom Manage (2008) 1.07
Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. Eur Psychiatry (2006) 1.05
Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS (2005) 1.03
Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med (2000) 1.02
A closer look at pain and hepatitis C: preliminary data from a veteran population. J Rehabil Res Dev (2007) 1.02
Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol (2006) 1.01
Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatr Serv (2006) 1.00
Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry (2007) 0.99
Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr (2004) 0.99
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol (1999) 0.99
Investigation of the validity of Halstead's measures of biological intelligence. AMA Arch Neurol Psychiatry (1955) 0.98
Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc (2004) 0.98
Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc (2005) 0.97
Cognitive impairment in substance abuse. Psychiatr Clin North Am (2004) 0.96
Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol (1997) 0.95
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther (2005) 0.88
Cognition in liver disease. Liver Int (2005) 0.87
Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C. J Int Neuropsychol Soc (2007) 0.87
Substance Dependence Severity Scale: reliability and validity for ICD-10 substance use disorders. Addict Behav (2001) 0.85
Neurocognitive impairment and dementia in mood disorders. J Neuropsychiatry Clin Neurosci (2007) 0.83
Differential display analysis of gene expression in brains from hepatitis C-infected patients. AIDS (2005) 0.82
Psychological, neuropsychological, and medical considerations in assessment and management of pain. J Head Trauma Rehabil (2004) 0.80
The influence of cognitive reserve on neuropsychological functioning following coronary artery bypass grafting (CABG). Arch Clin Neuropsychol (2006) 0.77
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 10.99
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09
Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement (2008) 2.52
TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol (2008) 2.23
Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas. Neuro Oncol (2009) 2.04
Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatment. Am J Psychiatry (2004) 1.96
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther (2005) 1.78
Clinical features and treatment prognosis of pathological gamblers with and without recent gambling-related illegal behavior. J Am Acad Psychiatry Law (2007) 1.67
Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology (2002) 1.63
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J Subst Abuse Treat (2006) 1.61
Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial. Psychosomatics (2010) 1.60
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol (2013) 1.54
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health (2004) 1.54
The phenomenology and treatment of interferon-induced depression. J Affect Disord (2004) 1.48
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders. Gen Hosp Psychiatry (2008) 1.42
Impaired tubulointerstitial expression of endothelin-1 and nitric oxide isoforms in donor kidney biopsies with postischemic acute renal failure. Transplantation (2003) 1.37
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Clin Cancer Res (2011) 1.35
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples. Psychol Assess (2004) 1.35
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol (2011) 1.33
Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design. J Infect Dis (2006) 1.31
Prenatal PCB exposure, the corpus callosum, and response inhibition. Environ Health Perspect (2003) 1.31
Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology (2003) 1.30
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol (2013) 1.27
Gambling level and psychiatric and medical disorders in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Geriatr Psychiatry (2006) 1.24
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs (2006) 1.20
Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis (2005) 1.14
A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord (2007) 1.11
Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett (2007) 1.07
Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett (2004) 1.07
Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. J Pain Symptom Manage (2008) 1.07
Prairie voles as a novel model of socially facilitated excessive drinking. Addict Biol (2011) 1.05
Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia (2003) 1.04
Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain (2013) 1.04
Facilitating outpatient treatment entry following detoxification for injection drug use: a multisite test of three interventions. Psychol Addict Behav (2009) 1.03
Alcohol intake in prairie voles is influenced by the drinking level of a peer. Alcohol Clin Exp Res (2011) 1.03
Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS (2005) 1.03
Observation of long-lived muonic hydrogen in the 2S state. Phys Rev Lett (2006) 1.02
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter. Ann Med (2005) 1.02
Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain (2012) 1.01
Evaluation of the psychometric properties of the revised short-form McGill Pain Questionnaire. J Pain (2012) 1.00
Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatr Serv (2006) 1.00
Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain (2012) 0.99
Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia (2002) 0.99
Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? Gen Hosp Psychiatry (2011) 0.99
Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol (2010) 0.97
Brief motivational interventions for college student problem gamblers. Addiction (2009) 0.97
Predictors of pain intensity and pain functioning in patients with the hepatitis C virus. Gen Hosp Psychiatry (2010) 0.95
Cognitive effects of pregabalin in healthy volunteers: a double-blind, placebo-controlled trial. Neurology (2010) 0.95
Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry (2008) 0.95
Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain Med (2011) 0.94
Treatment of cytokine-induced depression. Brain Behav Immun (2002) 0.94
Systematic review of the literature on pain in patients with polytrauma including traumatic brain injury. Pain Med (2009) 0.93
Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. J Clin Exp Neuropsychol (2010) 0.93
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder. Psychosomatics (2009) 0.92
Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant (2004) 0.92
Social housing and alcohol drinking in male-female pairs of prairie voles (Microtus ochrogaster). Psychopharmacology (Berl) (2012) 0.92
Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia. Schizophr Bull (2008) 0.91
Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions. Neuropsychol Rev (2013) 0.91
Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones (2005) 0.90
Dissociating neural subsystems for grammar by contrasting word order and inflection. Proc Natl Acad Sci U S A (2010) 0.90
Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats. Psychoneuroendocrinology (2006) 0.89
Safety of the treatment of interferon-alpha-induced depression. Psychosomatics (2003) 0.88
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. J Interferon Cytokine Res (2010) 0.88
Predictors of engaging in problem gambling treatment: data from the West Virginia Problem Gamblers Help Network. Psychol Addict Behav (2011) 0.87
Influence of mood state on capacity to consent to research in patients with bipolar disorder. Bipolar Disord (2008) 0.86
Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. J Affect Disord (2005) 0.84
Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord (2008) 0.84
Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection. Curr Opin Psychiatry (2009) 0.84
Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders. Subst Abuse Treat Prev Policy (2007) 0.84
Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res (2012) 0.83